GE HealthCare develops medical imaging, ultrasound, pharmaceutical diagnostics and AI-powered software for hospitals and health systems in 160+ countries.
GE HealthCare is a global healthcare solutions provider, tracing its origins to 1892 and operating as an independent public company since January 4th 2023, when it was spun off from General Electric and listed on Nasdaq. The company employs approximately 54,000 people and reported annual revenue of $20.6 billion. Its work spans medical imaging, ultrasound, pharmaceutical diagnostics, AI-powered software and care delivery.
The business is organised around four segments. Imaging supplies medical imaging equipment together with more than 200 imaging software applications for clinicians. Ultrasound covers ultrasound imaging technology. Patient Care Solutions focuses on patient care monitoring and care delivery, while Pharmaceutical Diagnostics provides diagnostic agents and related solutions. More than 5 million units of equipment are installed worldwide, and the company serves customers in over 160 countries, from remote regions such as Greenland to major medical centres.
GE HealthCare says its technology reaches over 1 billion patients a year. Annual investment in research and development and products exceeds $5.1 billion, and the company holds more than 11,000 granted patents globally. It states its purpose as creating a world where healthcare has no limits, with an emphasis on personalised, precise patient care and on improving hospital efficiency and clinical outcomes.
